Veterinary Infectious Disease Diagnostics Market by Technology (Immunodiagnostics, Molecular Diagnostics, and Others), Animal Type (Companion Animals and Food-Producing Animals), and End User (Reference Laboratories, Veterinary Hospitals & Clinics, Point-Of-Care/In-House Testing, and Research Institutes and Universities): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00026456 | Pages: 100 | Industry: Medical Device | Date: Sep 2022 | Type: Global

The market crossed US$ 1.70 billion mark in 2022 and is expected to hit US$ 3.34 billion by 2030, recording a CAGR of 8.8% during the forecast period.

Growing companion animal population and adoption rate will favor the market growth

Rising pet ownerships is one of the major factors driving the growth of the market. Having a companion animal is associated with positive health benefits, and the increasing pet population is expected to drive the demand for pet care products and services. For instance, according to a National Pet Owners Survey (2019–2020) conducted by the American Pet Products Association (APPA), about 67% (84.9 million families) of US households, owned a pet. This in turn, favor the growth of dependent industries such as veterinary infectious disease diagnostics. The immunodiagnostics segment is expected to grow due to emergence of advanced diagnostic immunoassay formats and diagnostic platforms. The improved immunoassay-based diagnostics tests offer improved accuracy in less time and effort. Thus, the growing popularity of immunodiagnostics and increase in the infectious diseases in animal will positively impact the veterinary infectious diseases diagnostics market in coming years.

Within the report, the veterinary infectious disease diagnostics market is segmented into technology, animal type, end user, and geography. By technology, the market is further segmented into immunodiagnostics, molecular diagnostics, and others. Based on animal type, the veterinary infectious disease diagnostics market is bifurcated into companion animals and food-producing animals. By end user, the market is categorized into reference laboratories, veterinary hospitals & clinics, point-of-care/in-house testing, and research institutes and universities. Geographically, the veterinary infectious disease diagnostics market is sub segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Get more information on this report :

North America holds a major share in the market.

Veterinary diagnostics is the processes and examinations conducted to identify the existence of infectious diseases. These procedures are performed via various methods by using their blood, feces, tissue samples. In addition, animal health has become a top priority for pet owners and farmers. Any negligence can lead to devastating results ranging from economic losses and disease spread to human fatalities. As a result, pet owners and farmers spend considerable amounts on veterinary diagnostic tests for early diagnosis of diseases in the animals. This boosts the sales of rapid diagnostic tests for infectious diseases, thereby fueling the growth of veterinary infectious disease diagnostics market. In addition, North America, American Pet Products Association survey 2019-2020 stated that around 42.7 million household’s own cats, 5.4 million owns small animals, and 1.6 million owns horses among others. The increasing number needs more diagnostic tests in the region as zoonotic diseases can spread quickly due to more human and animal interactions. The total United States pet industry expenditures is around US$ 75.38 billion in 2019-2020, risen from US$ 60.28 billion in 2015. Therefore, these factors are fueling the growth of veterinary infectious disease diagnostics market in the region.

Reference laboratories is the ideal destinations for veterinary infectious disease diagnostics.

Reference laboratories end-user segment holds significant share in the market owing to increase in the number of veterinary practitioners, high number of samples received for analysis in reference laboratories from small and large animal practices, growing pet adoption rates, and the rapid expansion of veterinary reference laboratory market. Moreover, veterinary infectious disease diagnostic technologies have become ideal solutions for the identification and detection of a range of animal diseases. Adoption of these highly effective tests helps end users in the early detection of animal diseases, in order to provide proper treatment in a timely manner.

Recent strategic developments in veterinary infectious disease diagnostics market.

The veterinary infectious disease diagnostics market has undergone several significant developments, and a few of these have been mentioned below:

  • In December 2020, Neogen Corporation launched Igenity Canine Wellness, a preventative care DNA screening tool for veterinarians. Awareness of genetic risks allows veterinary professionals to make more informed recommendations on diet, diagnostic screening, and lifestyle to enable a longer and happier life for each pet and their family.
  • In April 2021, Indical Bioscience GmbH (Germany) acquired Boehringer Ingelheim’s Svanova product portfolio to widen its portfolio by adding 25 assays for livestock.
  • In September 2021, Heska Corporation acquired majority ownership of Biotech Laboratories U.S.A. LLC, a leading developer of rapid assay diagnostics testing aims to support healthier animals by providing high-quality diagnostic solutions to veterinarians, livestock producers, and pet owners across the world.

 

The veterinary infectious disease diagnostics market is driven by several players of the market by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. bioMérieux; Neogen Corporation; Thermo Fisher Scientific; Randox Laboratories Ltd; IDEXX Laboratories, Inc.; IDVet; and Heska are among the prominent players operating in the market.

Target audience for the report:

  • Raw material providers
  • Service providers
  • Government bodies, such as regulating authorities and policy makers
  • Venture capitalists, private equity firms, and start-up companies
  • Sales firms
  • End users of diagnostic devices
  • Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented based on:

  • Technology:
    • Immunodiagnostics
    • Molecular Diagnostics
    • Others
  • Animal Type:
    • Companion Animals
    • Food-Producing Animals
  • End User:
    • Reference Laboratories
    • Veterinary Hospitals and Clinics
    • Point-Of-Care / In-House Testing
    • Research Institutes and Universities
  • Region:
    • North America
    • Europe
    • Asia Pacific (APAC)
    • South & Central America
    • Middle East & Africa
  • Companies profiled:
    • ioMérieux
    • Neogen Corporation
    • Thermo Fisher Scientific
    • Randox Laboratories Ltd
    • IDEXX Laboratories, Inc.
    • IDVet
    • Heska
    • BioChek
    • INDICAL BIOSCIENCE GmbH
    • Shenzhen Bioeasy Biotechnology Co., Ltd.

Companies profiled:
- bioM?rieux
- Neogen Corporation
- Thermo Fisher Scientific
- Randox Laboratories Ltd
- IDEXX Laboratories, Inc.
- IDVet
- Heska
- BioChek
- INDICAL BIOSCIENCE GmbH
- Shenzhen Bioeasy Biotechnology Co., Ltd.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$2000
Site License
$3000
Enterprise License
$4000